The season to make plan design changes is here! The National CooperativeRx account management team is ready to assist you with plan recommendations. If you are considering a change, please reach out to your designated account executive. Please keep the following deadlines in mind for changes to go into effect January 1, 2020: September 2,

As a clinical services manager, Jocelyn Kerl, PharmD., BCPS, makes up one-third of the National CooperativeRx clinical team. While overseeing her own book of business within the organization, she also plays a major role in daily clinical work. While anyone who interacts with Jocelyn is impressed by her immense knowledge, one would be surprised to

National CooperativeRx constantly monitors the pharmaceutical pipeline. As treatment options change, it’s important to know which drugs bring the highest value. Our quarterly NCRx Pipeline Reports provide insight from our clinical team on what changes you can expect to see on the market and how they impact plan performance. Mayzent: Mayzent is the first treatment

When it comes to the prescription drug debate, there’s no question pharmaceutical companies bring value to society. Most Americans have seen their quality of life improve because of a medication invented and/or brought to market by a pharmaceutical company. With maintenance medications being able to manage most chronic conditions today, Pharma is now helping those

In May, National CooperativeRx welcomed its first clinical intern, Jacky Yu, to the team for a six-week period. Jacky is a fourth-year pharmacy student at UW-Madison, currently with us for his first of six rotations required to become a licensed pharmacist. From Green Bay, Wis., Jacky received his undergraduate degree in biochemistry from UW-Madison, then

At our Annual Meeting in May, we highlighted the National CooperativeRx membership demographics. We assigned each group to an industry for the purpose of comparing utilization and costs to the programs and controls our membership have put in place. We assigned our Taft Hartley, and other health trusts, an industry most appropriate to their membership.

Please join us in welcoming our newest Board representative! Christine Wzorek, Representative at Four Foods Group (FFG), was elected to the National CooperativeRx Board of Directors at our Annual Meeting last month, effective immediately. FFG is a multi-unit restaurant chain company, based in Pleasant Grove, UT, with over 150 restaurant locations. Prior to FFG, Christine

Just like that, another year has flown by! National CooperativeRx hosted its 2019 Annual Meeting earlier this month, marking 15 years of providing our members best-in-class customer service and access to high-quality, cost-effective prescription drugs and services. Larry Richardson, Board Chair, began the morning by welcoming the largest Annual Meeting audience in history and introducing

As National CooperativeRx is member-owned and member-governed, it’s important our objectives align with those of our members. To ensure that, our Board of Directors is elected by membership. Applicants go through a vetting process performed by a committee of current board representatives, and member voting occurs online leading up to our Annual Membership Meeting. We’re

Skin cancer is the most common form of cancer in the US, with over 5 million cases diagnosed each year.1 However, skin cancer is also one of the most preventable types of cancer, and with May being Skin Cancer Awareness Month, it couldn’t be a better time to learn more about the disease and how to